2010 CLB Forum Topic Just Announced!

The Corporate Liaison Board (CLB) hosted the 10th Annual CLB Forum at ENDO 09:  “Biomarkers in Cardiovascular Endocrinology in Clinical Trials & Drug Development,” which highlighted the collaboration between industry, academia, and government in approaches to treatment of endocrine disorders.  The program included the following topics:

• The Mandate for Development of Biomarkers of Atherosclerotic Cardiovascular Disease: Future Implications, David A. Fryburg, MD
• Novel Cardiovascular Biomarkers: Experience with Lp-PLA2 , Joseph P. McConnell, PhD
• Biomarkers in Cardiovascular Endocrinology in Clinical Trials & Drug Development:  Regulatory Perspective, Mary H. Parks, MD

This was an extremely popular program with 93% of attendees stating that they would recommend the program to their colleagues.  Comments ranged from “excellent topics” to “very interesting and important topics – well presented”.

Don’t miss another great program in 2010 on Friday, June 18^th, 6:30-9:30 pm led by Program Director, S. Sethu K. Reddy, MD, MBA – Merck & Co.  The program will take place immediately after Diabetes Management Day and is titled, “Application of Technology to Improve Diabetes Care – Navigating the Labyrinth” and includes the following topics:

• Continuous Glucose Monitoring
  David Klonoff, MD, American Diabetes Technology Society
• Non-Invasive Glucose Management
  Patricia Beaston, MD/PhD, Office of In Vitro Diagnostics FDA
• Artificial Pancreas
   Francine Kaufman, MD, Medtronic Minimed, Inc.

To learn more about the 2010 CLB Forum, please visit the ENDO 2010 Web site.  Registration will be open in December 2009. There is no cost to attend this event, but seating reservations are on a first-come, first-served basis. In order to receive more information, please contact Nancy Chill at nchill@endo-society.org or 301-941-0203. We look forward to seeing you in San Diego.